Abbott Laboratories (NYSE:ABT)

59.71
Delayed Data
As of Feb 23
 +0.72 / +1.22%
Today’s Change
42.31
Today|||52-Week Range
64.60
+4.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues6.3B6.6B6.8B7.6B
 
 
 
 
 
Cost of Goods Sold2.8B2.9B2.6B2.9B
 
 
 
 
 
Depreciation And Amortization774.0M648.0M756.0M843.0M
 
 
 
 
 
 
Operating ExpensesGross Income2.8B3.1B3.5B3.8B
 
 
 
 
 
General Expenses2.8B2.6B2.6B3.0B
 
 
 
 
 
Research And Development541.0M512.0M493.0M559.0M
 
 
 
 
 
Total Operating Expenses6.4B6.2B5.9B6.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-66.0M455.0M905.0M830.0M
 
 
 
 
 
Extraordinary Charge-131.0M-26.0M-88.0M-64.0M
 
 
 
 
 
Interest Expense On Debt207.0M181.0M224.0M261.0M
 
 
 
 
 
Other Expenses1.1B9.0M-8.0M-79.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income736.0M295.0M626.0M574.0M
 
 
 
 
 
Income Taxes-350.0M-25.0M-65.0M-1.4B
 
 
 
 
 
Discontinued Operations33.0M13.0M42.0M36.0M
 
 
 
 
 
Net Income417.0M282.0M600.0M-831.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7B1.7B1.7B1.7B
 
 
 
 
 
Shares To Calculate EPS Diluted1.7B1.7B1.8B1.7B
 
 
 
 
 
 
Earnings Per ShareEPS$0.24$0.16$0.34-$0.48
 
 
 
 
 
EPS Diluted$0.24$0.16$0.34-$0.47